Effect of statins on abdominal aortic aneurysm

Eur J Pharm Sci. 2022 Nov 1:178:106284. doi: 10.1016/j.ejps.2022.106284. Epub 2022 Aug 26.

Abstract

Abdominal aortic aneurysm (AAA) is a prevalent condition which causes progressive growth and rupture of aortic wall with a high death rate. Several studies have found that treatment with statins may decrease the progress of AAA and the risk of rupture by suppressing the inflammatory mediators, decreasing oxidative stress, and inhibiting mechanisms involved in extracellular matrix (ECM) degradation. Moreover, some studies have reported that prehospital therapy with statins can decrease mortality after surgery. The novelty of this paper is that different studies including those performed in humans and animals were reviewed and the potential mechanisms by which statins can have an effect on AAA were summarized. Overall, the evidence suggested an association between treatment with statins and improvement of AAA.

Keywords: Abdominal aortic aneurysm; Extracellular matrix; Inflammation; Oxidative stress; Statins.

Publication types

  • Review

MeSH terms

  • Animals
  • Aorta / metabolism
  • Aortic Aneurysm, Abdominal* / drug therapy
  • Aortic Aneurysm, Abdominal* / metabolism
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / pharmacology
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Inflammation Mediators / metabolism
  • Oxidative Stress

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Inflammation Mediators